Table 2.
Patients’ characteristics stratified by sperm retrieval outcome
| Median (IQR) | p value | Mean (SD) | p value | |||
|---|---|---|---|---|---|---|
| mTESE outcome | mTESE outcome | |||||
| Successful (n = 11) | Unsuccessful (n = 12) | Successful (n = 11) | Unsuccessful (n = 12) | |||
| Male age at TESE, years | 38 (34–40.5) | 40 (33–41) | .740 | 38.0 (5.7) | 36.7 (5.7) | .740 |
| Male FSH, mIU/ml | 22.3 (17.1–24.9) | 19.6 (15–24.1) | .651 | 22.4 (14.7) | 19.6 (8.2) | .651 |
| Male LH, mIU/ml | 7.2 (6.5–10.9) | 7.6 (5.8–11.1) | .928 | 8.7 (4.6) | 8.9 (5.3) | .928 |
| Male testosterone, ng/ml | 4.4 (3.3–4.9) | 2.2 (1.8–3.0) | .079 | 5.1 (4.5) | 3.1 (2.5) | .079 |
| Male prolactin, ng/ml | 10.6 (8.9–15.4) | 8.5 (5.2–10.3) | .059 | 10.6 (4.7) | 9.6 (5.1) | .059 |
| Male estradiol, pg/ml | 19.5 (19.0–29.6) | 18.7 (16.8–21.5) | .316 | 24.9 (14.7) | 25.2 (22.6) | .316 |
| Time from C/T to mTESE, years | 7 (5–18.5) | 10 (4–19) | .928 | 10.8 (8.5) | 12.7 (12.7) | .928 |
| Testis volume, ml | 13 (10–16.5) | 11 (8–17) | .525 | 13.4 (4.7) | 12.8 (7.3) | .525 |
| Alkylating agents exposure, number | 1 (9%) | 8 (67%) | .009 | 1 (9%) | 8 (67%) | .009 |
| CED dose, mg/m2 | 0 (0–0) | 3049.8 (0–8470.6) | .012 | 249.0 (825.8) | 8523.2 (14,891.5) | .012 |
| Platinum-based agents exposure, number | 8 (73%) | 7 (58%) | .667 | 8 (73%) | 7 (58%) | .667 |
| Accumulative cisplatin dose, mg/m2 | 294.1 (0–347.5) | 45.3 (0–336.2) | .928 | 218.2 (228.6) | 181.5 (228.6) | .928 |